Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Dose Nexium 40MG QAM vs Lansoprazole 30mg BID for Control of Symptomatic GERD-A Double Blind Cross-Over Study

NCT00295685 is registered in ClinicalTrials.gov with Digestive & Liver Disease Specialists as lead sponsor.

NCT NCT00295685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00295685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Dose Nexium 40MG QAM vs Lansoprazole 30mg BID for Control of Symptomatic GERD-A Double Blind Cross-Over Study
Lead sponsor
Digestive & Liver Disease Specialists
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2005
Completion date
December 31, 2007
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gerd